aluates Reports

$ 0.0

Automative

Global Intravenous Immune Globulin Therapies Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-20U13500

Global Intravenous Immune Globulin Therapies Market Research Report 2023

BUY CHAPTERS

Global Intravenous Immune Globulin Therapies Market Research Report 2025

Code: QYRE-Auto-20U13500

Report

September 2025

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Baxter

Grifols S A

CSL Plasma

Octapharma AG

Biotest

Kedrion S p A

Kamada

China Biologic Products Holdings

Hualan Biological Engineering

Sichuan Yuanda Shuyang Pharmaceutical

Intravenous Immune Globulin Therapies Market

The global market for Intravenous Immune Globulin Therapies was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Immune globulin derived from the plasma of paid and volunteer donors is used in the treatment of an array of disorders, including primary and secondary immune deficiency states and a variety of autoimmune and inflammatory disorders.

North American market for Intravenous Immune Globulin Therapies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Intravenous Immune Globulin Therapies is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Intravenous Immune Globulin Therapies in Immunodeficiency is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Intravenous Immune Globulin Therapies include Baxter, Grifols, CSL Plasma, Octapharma, Biotest, Kedrion, Kamada, China Biologic Products Holdings, Hualan Biological Engineering, Sichuan Yuanda Shuyang Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Intravenous Immune Globulin Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Immune Globulin Therapies.

The Intravenous Immune Globulin Therapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Intravenous Immune Globulin Therapies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Intravenous Immune Globulin Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Intravenous Immune Globulin Therapies Market Report

Report Metric	Details
Report Name	Intravenous Immune Globulin Therapies Market
Segment by Type	Liquid Form Lyophilized Powder Form
Segment by Application	Immunodeficiency Autoimmune Disease Acute Infection
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Baxter, Grifols, CSL Plasma, Octapharma, Biotest, Kedrion, Kamada, China Biologic Products Holdings, Hualan Biological Engineering, Sichuan Yuanda Shuyang Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Intravenous Immune Globulin Therapies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Intravenous Immune Globulin Therapies Market report?

Ans: The main players in the Intravenous Immune Globulin Therapies Market are Baxter, Grifols, CSL Plasma, Octapharma, Biotest, Kedrion, Kamada, China Biologic Products Holdings, Hualan Biological Engineering, Sichuan Yuanda Shuyang Pharmaceutical

What are the Application segmentation covered in the Intravenous Immune Globulin Therapies Market report?

Ans: The Applications covered in the Intravenous Immune Globulin Therapies Market report are Immunodeficiency, Autoimmune Disease, Acute Infection

What are the Type segmentation covered in the Intravenous Immune Globulin Therapies Market report?

Ans: The Types covered in the Intravenous Immune Globulin Therapies Market report are Liquid Form, Lyophilized Powder Form

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Intravenous Immune Globulin Therapies Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Liquid Form

1.2.3 Lyophilized Powder Form

1.3 Market by Application

1.3.1 Global Intravenous Immune Globulin Therapies Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Immunodeficiency

1.3.3 Autoimmune Disease

1.3.4 Acute Infection

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Intravenous Immune Globulin Therapies Market Perspective (2020-2031)

2.2 Global Intravenous Immune Globulin Therapies Growth Trends by Region

2.2.1 Global Intravenous Immune Globulin Therapies Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Intravenous Immune Globulin Therapies Historic Market Size by Region (2020-2025)

2.2.3 Intravenous Immune Globulin Therapies Forecasted Market Size by Region (2026-2031)

2.3 Intravenous Immune Globulin Therapies Market Dynamics

2.3.1 Intravenous Immune Globulin Therapies Industry Trends

2.3.2 Intravenous Immune Globulin Therapies Market Drivers

2.3.3 Intravenous Immune Globulin Therapies Market Challenges

2.3.4 Intravenous Immune Globulin Therapies Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Intravenous Immune Globulin Therapies Players by Revenue

3.1.1 Global Top Intravenous Immune Globulin Therapies Players by Revenue (2020-2025)

3.1.2 Global Intravenous Immune Globulin Therapies Revenue Market Share by Players (2020-2025)

3.2 Global Intravenous Immune Globulin Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Intravenous Immune Globulin Therapies Revenue

3.4 Global Intravenous Immune Globulin Therapies Market Concentration Ratio

3.4.1 Global Intravenous Immune Globulin Therapies Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Intravenous Immune Globulin Therapies Revenue in 2024

3.5 Global Key Players of Intravenous Immune Globulin Therapies Head office and Area Served

3.6 Global Key Players of Intravenous Immune Globulin Therapies, Product and Application

3.7 Global Key Players of Intravenous Immune Globulin Therapies, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Intravenous Immune Globulin Therapies Breakdown Data by Type

4.1 Global Intravenous Immune Globulin Therapies Historic Market Size by Type (2020-2025)

4.2 Global Intravenous Immune Globulin Therapies Forecasted Market Size by Type (2026-2031)

5 Intravenous Immune Globulin Therapies Breakdown Data by Application

5.1 Global Intravenous Immune Globulin Therapies Historic Market Size by Application (2020-2025)

5.2 Global Intravenous Immune Globulin Therapies Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Intravenous Immune Globulin Therapies Market Size (2020-2031)

6.2 North America Intravenous Immune Globulin Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Intravenous Immune Globulin Therapies Market Size by Country (2020-2025)

6.4 North America Intravenous Immune Globulin Therapies Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Intravenous Immune Globulin Therapies Market Size (2020-2031)

7.2 Europe Intravenous Immune Globulin Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Intravenous Immune Globulin Therapies Market Size by Country (2020-2025)

7.4 Europe Intravenous Immune Globulin Therapies Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Intravenous Immune Globulin Therapies Market Size (2020-2031)

8.2 Asia-Pacific Intravenous Immune Globulin Therapies Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Intravenous Immune Globulin Therapies Market Size by Region (2020-2025)

8.4 Asia-Pacific Intravenous Immune Globulin Therapies Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Intravenous Immune Globulin Therapies Market Size (2020-2031)

9.2 Latin America Intravenous Immune Globulin Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Intravenous Immune Globulin Therapies Market Size by Country (2020-2025)

9.4 Latin America Intravenous Immune Globulin Therapies Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Intravenous Immune Globulin Therapies Market Size (2020-2031)

10.2 Middle East & Africa Intravenous Immune Globulin Therapies Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Country (2020-2025)

10.4 Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Baxter

11.1.1 Baxter Company Details

11.1.2 Baxter Business Overview

11.1.3 Baxter Intravenous Immune Globulin Therapies Introduction

11.1.4 Baxter Revenue in Intravenous Immune Globulin Therapies Business (2020-2025)

11.1.5 Baxter Recent Development

11.2 Grifols

11.2.1 Grifols Company Details

11.2.2 Grifols Business Overview

11.2.3 Grifols Intravenous Immune Globulin Therapies Introduction

11.2.4 Grifols Revenue in Intravenous Immune Globulin Therapies Business (2020-2025)

11.2.5 Grifols Recent Development

11.3 CSL Plasma

11.3.1 CSL Plasma Company Details

11.3.2 CSL Plasma Business Overview

11.3.3 CSL Plasma Intravenous Immune Globulin Therapies Introduction

11.3.4 CSL Plasma Revenue in Intravenous Immune Globulin Therapies Business (2020-2025)

11.3.5 CSL Plasma Recent Development

11.4 Octapharma

11.4.1 Octapharma Company Details

11.4.2 Octapharma Business Overview

11.4.3 Octapharma Intravenous Immune Globulin Therapies Introduction

11.4.4 Octapharma Revenue in Intravenous Immune Globulin Therapies Business (2020-2025)

11.4.5 Octapharma Recent Development

11.5 Biotest

11.5.1 Biotest Company Details

11.5.2 Biotest Business Overview

11.5.3 Biotest Intravenous Immune Globulin Therapies Introduction

11.5.4 Biotest Revenue in Intravenous Immune Globulin Therapies Business (2020-2025)

11.5.5 Biotest Recent Development

11.6 Kedrion

11.6.1 Kedrion Company Details

11.6.2 Kedrion Business Overview

11.6.3 Kedrion Intravenous Immune Globulin Therapies Introduction

11.6.4 Kedrion Revenue in Intravenous Immune Globulin Therapies Business (2020-2025)

11.6.5 Kedrion Recent Development

11.7 Kamada

11.7.1 Kamada Company Details

11.7.2 Kamada Business Overview

11.7.3 Kamada Intravenous Immune Globulin Therapies Introduction

11.7.4 Kamada Revenue in Intravenous Immune Globulin Therapies Business (2020-2025)

11.7.5 Kamada Recent Development

11.8 China Biologic Products Holdings

11.8.1 China Biologic Products Holdings Company Details

11.8.2 China Biologic Products Holdings Business Overview

11.8.3 China Biologic Products Holdings Intravenous Immune Globulin Therapies Introduction

11.8.4 China Biologic Products Holdings Revenue in Intravenous Immune Globulin Therapies Business (2020-2025)

11.8.5 China Biologic Products Holdings Recent Development

11.9 Hualan Biological Engineering

11.9.1 Hualan Biological Engineering Company Details

11.9.2 Hualan Biological Engineering Business Overview

11.9.3 Hualan Biological Engineering Intravenous Immune Globulin Therapies Introduction

11.9.4 Hualan Biological Engineering Revenue in Intravenous Immune Globulin Therapies Business (2020-2025)

11.9.5 Hualan Biological Engineering Recent Development

11.10 Sichuan Yuanda Shuyang Pharmaceutical

11.10.1 Sichuan Yuanda Shuyang Pharmaceutical Company Details

11.10.2 Sichuan Yuanda Shuyang Pharmaceutical Business Overview

11.10.3 Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Introduction

11.10.4 Sichuan Yuanda Shuyang Pharmaceutical Revenue in Intravenous Immune Globulin Therapies Business (2020-2025)

11.10.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Baxter

Grifols S A

CSL Plasma

Octapharma AG

Biotest

Kedrion S p A

Kamada

China Biologic Products Holdings

Hualan Biological Engineering

Sichuan Yuanda Shuyang Pharmaceutical

List of Tables

Table 1. Global Intravenous Immune Globulin Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Liquid Form

Table 3. Key Players of Lyophilized Powder Form

Table 4. Global Intravenous Immune Globulin Therapies Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Intravenous Immune Globulin Therapies Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Intravenous Immune Globulin Therapies Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Intravenous Immune Globulin Therapies Market Share by Region (2020-2025)

Table 8. Global Intravenous Immune Globulin Therapies Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Intravenous Immune Globulin Therapies Market Share by Region (2026-2031)

Table 10. Intravenous Immune Globulin Therapies Market Trends

Table 11. Intravenous Immune Globulin Therapies Market Drivers

Table 12. Intravenous Immune Globulin Therapies Market Challenges

Table 13. Intravenous Immune Globulin Therapies Market Restraints

Table 14. Global Intravenous Immune Globulin Therapies Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Intravenous Immune Globulin Therapies Market Share by Players (2020-2025)

Table 16. Global Top Intravenous Immune Globulin Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immune Globulin Therapies as of 2024)

Table 17. Ranking of Global Top Intravenous Immune Globulin Therapies Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Intravenous Immune Globulin Therapies Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Intravenous Immune Globulin Therapies, Headquarters and Area Served

Table 20. Global Key Players of Intravenous Immune Globulin Therapies, Product and Application

Table 21. Global Key Players of Intravenous Immune Globulin Therapies, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Intravenous Immune Globulin Therapies Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Intravenous Immune Globulin Therapies Revenue Market Share by Type (2020-2025)

Table 25. Global Intravenous Immune Globulin Therapies Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Intravenous Immune Globulin Therapies Revenue Market Share by Type (2026-2031)

Table 27. Global Intravenous Immune Globulin Therapies Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Intravenous Immune Globulin Therapies Revenue Market Share by Application (2020-2025)

Table 29. Global Intravenous Immune Globulin Therapies Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Intravenous Immune Globulin Therapies Revenue Market Share by Application (2026-2031)

Table 31. North America Intravenous Immune Globulin Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Intravenous Immune Globulin Therapies Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Intravenous Immune Globulin Therapies Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Intravenous Immune Globulin Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Intravenous Immune Globulin Therapies Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Intravenous Immune Globulin Therapies Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Intravenous Immune Globulin Therapies Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Intravenous Immune Globulin Therapies Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Intravenous Immune Globulin Therapies Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Intravenous Immune Globulin Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Intravenous Immune Globulin Therapies Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Intravenous Immune Globulin Therapies Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Intravenous Immune Globulin Therapies Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Country (2026-2031) & (US$ Million)

Table 46. Baxter Company Details

Table 47. Baxter Business Overview

Table 48. Baxter Intravenous Immune Globulin Therapies Product

Table 49. Baxter Revenue in Intravenous Immune Globulin Therapies Business (2020-2025) & (US$ Million)

Table 50. Baxter Recent Development

Table 51. Grifols Company Details

Table 52. Grifols Business Overview

Table 53. Grifols Intravenous Immune Globulin Therapies Product

Table 54. Grifols Revenue in Intravenous Immune Globulin Therapies Business (2020-2025) & (US$ Million)

Table 55. Grifols Recent Development

Table 56. CSL Plasma Company Details

Table 57. CSL Plasma Business Overview

Table 58. CSL Plasma Intravenous Immune Globulin Therapies Product

Table 59. CSL Plasma Revenue in Intravenous Immune Globulin Therapies Business (2020-2025) & (US$ Million)

Table 60. CSL Plasma Recent Development

Table 61. Octapharma Company Details

Table 62. Octapharma Business Overview

Table 63. Octapharma Intravenous Immune Globulin Therapies Product

Table 64. Octapharma Revenue in Intravenous Immune Globulin Therapies Business (2020-2025) & (US$ Million)

Table 65. Octapharma Recent Development

Table 66. Biotest Company Details

Table 67. Biotest Business Overview

Table 68. Biotest Intravenous Immune Globulin Therapies Product

Table 69. Biotest Revenue in Intravenous Immune Globulin Therapies Business (2020-2025) & (US$ Million)

Table 70. Biotest Recent Development

Table 71. Kedrion Company Details

Table 72. Kedrion Business Overview

Table 73. Kedrion Intravenous Immune Globulin Therapies Product

Table 74. Kedrion Revenue in Intravenous Immune Globulin Therapies Business (2020-2025) & (US$ Million)

Table 75. Kedrion Recent Development

Table 76. Kamada Company Details

Table 77. Kamada Business Overview

Table 78. Kamada Intravenous Immune Globulin Therapies Product

Table 79. Kamada Revenue in Intravenous Immune Globulin Therapies Business (2020-2025) & (US$ Million)

Table 80. Kamada Recent Development

Table 81. China Biologic Products Holdings Company Details

Table 82. China Biologic Products Holdings Business Overview

Table 83. China Biologic Products Holdings Intravenous Immune Globulin Therapies Product

Table 84. China Biologic Products Holdings Revenue in Intravenous Immune Globulin Therapies Business (2020-2025) & (US$ Million)

Table 85. China Biologic Products Holdings Recent Development

Table 86. Hualan Biological Engineering Company Details

Table 87. Hualan Biological Engineering Business Overview

Table 88. Hualan Biological Engineering Intravenous Immune Globulin Therapies Product

Table 89. Hualan Biological Engineering Revenue in Intravenous Immune Globulin Therapies Business (2020-2025) & (US$ Million)

Table 90. Hualan Biological Engineering Recent Development

Table 91. Sichuan Yuanda Shuyang Pharmaceutical Company Details

Table 92. Sichuan Yuanda Shuyang Pharmaceutical Business Overview

Table 93. Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Product

Table 94. Sichuan Yuanda Shuyang Pharmaceutical Revenue in Intravenous Immune Globulin Therapies Business (2020-2025) & (US$ Million)

Table 95. Sichuan Yuanda Shuyang Pharmaceutical Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Intravenous Immune Globulin Therapies Picture

Figure 2. Global Intravenous Immune Globulin Therapies Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Intravenous Immune Globulin Therapies Market Share by Type: 2024 VS 2031

Figure 4. Liquid Form Features

Figure 5. Lyophilized Powder Form Features

Figure 6. Global Intravenous Immune Globulin Therapies Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Intravenous Immune Globulin Therapies Market Share by Application: 2024 VS 2031

Figure 8. Immunodeficiency Case Studies

Figure 9. Autoimmune Disease Case Studies

Figure 10. Acute Infection Case Studies

Figure 11. Intravenous Immune Globulin Therapies Report Years Considered

Figure 12. Global Intravenous Immune Globulin Therapies Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Intravenous Immune Globulin Therapies Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Intravenous Immune Globulin Therapies Market Share by Region: 2024 VS 2031

Figure 15. Global Intravenous Immune Globulin Therapies Market Share by Players in 2024

Figure 16. Global Top Intravenous Immune Globulin Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immune Globulin Therapies as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Intravenous Immune Globulin Therapies Revenue in 2024

Figure 18. North America Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Intravenous Immune Globulin Therapies Market Share by Country (2020-2031)

Figure 20. United States Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Intravenous Immune Globulin Therapies Market Share by Country (2020-2031)

Figure 24. Germany Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Intravenous Immune Globulin Therapies Market Share by Region (2020-2031)

Figure 32. China Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Intravenous Immune Globulin Therapies Market Share by Country (2020-2031)

Figure 40. Mexico Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Intravenous Immune Globulin Therapies Market Share by Country (2020-2031)

Figure 44. Turkey Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Intravenous Immune Globulin Therapies Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Baxter Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2020-2025)

Figure 48. Grifols Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2020-2025)

Figure 49. CSL Plasma Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2020-2025)

Figure 50. Octapharma Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2020-2025)

Figure 51. Biotest Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2020-2025)

Figure 52. Kedrion Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2020-2025)

Figure 53. Kamada Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2020-2025)

Figure 54. China Biologic Products Holdings Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2020-2025)

Figure 55. Hualan Biological Engineering Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2020-2025)

Figure 56. Sichuan Yuanda Shuyang Pharmaceutical Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Intravenous Immunoglobulin IVIg Market Research Report 2025

Immune Globulin Intravenous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Immune Globulin Intravenous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hyperimmune Globulin Product Market Research Report 2024

Human Plasma derived Hyperimmune Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Hyperimmune Globulins Market Research Report 2024

Global Hyperimmune Globulin Injection Market Research Report 2024

Global Intravenous Injection Immunoglobulin Market Research Report 2024

IVIg Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Plasma Protein Products Market Research Report 2024

Hyper Immune Globulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Plasma based Hyperimmune Preparation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Immune Globulin Subcutaneous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Immumoglobulin PH4 for Intravenous Injection Market Insights Forecast to 2030

IVIg Liquid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lyophilized IVIG Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hyperimmune Globulins Market Research Report 2025

Animal derived Immune Globulin Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Immune Globulins Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions